GenSight Biologics Market Cap

GenSight Biologics has a market cap or net worth of €31.96 million as of December 20, 2024. Its market cap has increased by 15.02% in one year.

Market Cap

31.96M

Enterprise Value

47.70M

Revenue

1.98M

Ranking

n/a

PE Ratio

n/a

Stock Price

€0.27

Market Cap Chart

Since July 13, 2016, GenSight Biologics's market cap has decreased from 252.15M to 31.96M, a decrease of -87.33%. That is a compound annual growth rate of -21.70%.

Market Cap History

Date	Market Cap	% Change
Dec 20, 2024	31.96M	24.52%
Dec 29, 2023	25.66M	-83.46%
Dec 30, 2022	155.20M	-39.23%
Dec 31, 2021	255.38M	-16.09%
Dec 31, 2020	304.35M	275.09%
Dec 31, 2019	81.14M	-1.47%
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Sanofi	114.43B
EssilorLuxottica Société anonyme	105.61B
Sartorius Stedim Biotech S.A.	18.02B
bioMérieux S.A.	12.06B
Eurofins Scientific SE	9.08B
Ipsen S.A.	8.88B
Virbac SA	2.59B
Ramsay Générale de Santé SA	1.25B

Market Cap Rankings